Alembic Pharmaceuticals Limited (BOM:533573)
1,041.40
-7.35 (-0.70%)
At close: Nov 20, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 204.61 billion as of November 20, 2026. Its market cap has increased by 14.86% in one year.
Market Cap
204.61B
Enterprise Value
217.39B
Revenue
84.77B
Global Rank
n/a
Country Rank
n/a
PE Ratio
24.25
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 204.61B, an increase of 2,173.06%. That is a compound annual growth rate of 22.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 204.61B | 23.02% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 443.66B |
| Ajanta Pharma | 414.52B |
| Wockhardt | 353.36B |
| Piramal Pharma | 317.20B |
| Alembic Pharmaceuticals | 205.40B |
| Eris Lifesciences | 182.30B |
| Cohance Lifesciences | 176.95B |
| Alivus Life Sciences | 176.79B |